Covered recipient · General Payments record
KARA H MONGER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2025
$936.34
- Reported across 27 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $323.57 | 14 |
| Education | $158.00 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $257.55 | 6 |
| Organon LLC | $60.69 | 2 |
| Biogen, Inc. | $59.93 | 3 |
| PFIZER INC. | $39.48 | 2 |
| Merck Sharp & Dohme Corporation | $27.26 | 1 |
| Exact Sciences Corporation | $19.62 | 1 |
| Lilly USA, LLC | $17.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $29.80 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238658138 | CMS |
| Astellas Pharma US Inc | $22.65 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238690978 | CMS |
| Astellas Pharma US Inc | $18.96 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238576033 | CMS |
| Astellas Pharma US Inc | $90.05 | 10/30/2025 | Education | Undisputed | 06/30/2026 | 1238586096 | CMS |
| Astellas Pharma US Inc | $67.95 | 10/30/2025 | Education | Undisputed | 06/30/2026 | 1238586288 | CMS |
| Astellas Pharma US Inc | $28.14 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238588304 | CMS |
| Biogen, Inc. | $16.97 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208377147 | CMS |
| Biogen, Inc. | $21.94 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208380604 | CMS |
| Biogen, Inc. | $21.02 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208326481 | CMS |
| Exact Sciences Corporation | $19.62 | 08/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235267143 | CMS |
| Lilly USA, LLC | $17.04 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187134061 | CMS |
| Merck Sharp & Dohme LLC | $27.26 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238128603 | CMS |
| Organon LLC | $29.72 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237659904 | CMS |
| Organon LLC | $30.97 | 11/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237659906 | CMS |
| PFIZER INC. | $13.96 | 09/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230574419 | CMS |
| PFIZER INC. | $25.52 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231031521 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2025
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.